The latest market analysis reveals a promising outlook for the global traditional wound management market, which saw an increase from USD 5,059.1 million in 2022 to USD 5,185.6 million in 2023. With a ...

In 2023, the market for negative pressure wound therapy is projected to be worth USD 6.5 billion. By 2033, the market is ...

The Terasaki Institute has created an injectable, porous dermal filler made from biocompatible materials that enhances ...

(OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived biologics for advanced wound care, announces breakthrough results ...

"This technology marks a major breakthrough in wound care and management ... This innovative approach to treating diabetic foot ulcers represents exactly the kind of clinically translational ...

Soft-tissue repair company Aroa Biosurgery (ASX:ARX) is looking for US expansion with the wound ... original products designed for chronic and acute wounds including diabetic foot ulcers and ...

Research shows elevated metformin in diabetic foot ulcer exudates when combined with ... and Alcohol Dependence seeks to understand the wound care experiences of this population.

"This technology marks a major breakthrough in wound ... treating diabetic foot ulcers represents exactly the kind of clinically translational technology we need in modern health care," said ...

A: Although popular perception may seem to indicate otherwise, current data is not sufficient to conclude that pressure ulcer rates at long-term care facilities are higher than those of hospitals.

Retrospective Study demonstrates clinical efficacy and statistical support for tissue processed via BioREtain to care for treatment-resistant chronic wounds Study published in the peer-reviewed ...

The proportion of wounds healed at 16 weeks was higher with intact fish skin grafts than with standard-of-care ... diabetic wound classification system] grade 2 and 3 diabetic foot ulcers and ...